The bone morphogenetic protein market is estimated to be valued at US$ 342.3 Mn in 2024 and is expected to exhibit a CAGR of 3.8% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights. The bone morphogenetic protein market is primarily driven by increasing incidence of spinal fusion surgeries and Read More…
